Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Bavarian doses first patient in CV301 and atezolizumab Phase ll trial

Human urinary bladder. Credit: Jpogi.

Go Top